pfizer

UK regulator approves updated Pfizer-BioNTech COVID vaccine, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites Bengaluru: The UK drug regulator said on Tuesday it has approved an updated COVID-19 vaccine by Pfizer and its German partner BioNTech that targets only the Omicron XBB.1.5 subvariant. The vaccine, which like their other COVID shots will also be sold under brand Comirnaty, has been approved for use in individuals aged …

UK regulator approves updated Pfizer-BioNTech COVID vaccine, ET HealthWorld Read More »

New Covid vaccines are on the way as ‘Eris’ variant rises, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites New York: A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly received even as hospitalizations from “Eris”, a variant of the Omicron form of the coronavirus, rise around the country. Some public health experts hope that Americans will welcome the …

New Covid vaccines are on the way as ‘Eris’ variant rises, ET HealthWorld Read More »

Global COVID cases up 80 per cent as new subvariant rises, Health News, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites Paris:The number of new COVID-19 cases reported worldwide rose by 80 percent in the last month, the World Health Organisation said on Friday, days after designating a new “variant of interest”. The WHO declared in May that COVID is no longer a global health emergency, but has warned that the virus will …

Global COVID cases up 80 per cent as new subvariant rises, Health News, ET HealthWorld Read More »

Pfizer considers cost cuts as demand for COVID products falls, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites Bengaluru: Pfizer on Tuesday said it will launch a cost-cutting program if its COVID-19 vaccine and antiviral treatment keep underperforming expectations in the coming months due to plunging demand. Pfizer said it anticipates more clarity on the future size of the COVID market later this year as infection rates rise in the …

Pfizer considers cost cuts as demand for COVID products falls, ET HealthWorld Read More »

US NIH launches long-COVID trials of Pfizer’s Paxlovid, other therapies, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites Bengaluru: The U.S. National Institutes of Health (NIH) said on Monday that it had launched mid-stage clinical trials to test at least four treatments, including Pfizer‘s Paxlovid, in patients with symptoms of long COVID. The studies are designed to evaluate multiple therapies, where the first part of trial will test a longer …

US NIH launches long-COVID trials of Pfizer’s Paxlovid, other therapies, ET HealthWorld Read More »

China’s CSPC Pharma partners with Pfizer for oral COVID treatment, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites Bengaluru: Chinese drug maker CSPC Pharmaceutical Group said on Thursday it signed a strategic partnership with Pfizer to launch a local brand of an oral COVID-19 treatment, in an attempt to improve the access for treatment in China. The combination of Nirmatrelvir and Ritonavir sold under the brand name Paxlovid, an oral …

China’s CSPC Pharma partners with Pfizer for oral COVID treatment, ET HealthWorld Read More »

US FDA approves Pfizer-OPKO’s drug for growth hormone deficiency in kids, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites Bengaluru: The U.S. Food and Drug Administration has approved Pfizer Inc and partner OPKO Health Inc’s treatment for growth hormone deficiency in children, the companies said on Wednesday. The approval for the drug, which comes after an initial rejection from the FDA in January last year, lifted Pfizer’s shares marginally and Opko …

US FDA approves Pfizer-OPKO’s drug for growth hormone deficiency in kids, ET HealthWorld Read More »

First gene therapy for deadly form of muscular dystrophy gets FDA approval for young kids, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites Washington: The first gene therapy for a deadly form of muscular dystrophy received preliminary US approval on Thursday despite concerns from some government scientists about the treatment’s ability to help boys with the inherited disease. The Food and Drug Administration approval provides a new option for some patients with Duchenne muscular dystrophy, …

First gene therapy for deadly form of muscular dystrophy gets FDA approval for young kids, ET HealthWorld Read More »


Wallet

Community

Home

Favourites

Messages

New Report

Close

×